In a sector that has continued to remain in growth mode, it’s important to ensure that organizations meet the regulatory standards set forth. Reinvesting profits can help you take advantage of a trending marketplace. At KPMG, we help clients meet regulatory guidelines, revitalize telehealth platforms, and increase member utilization and loyalty. Our professionals are dedicated to driving member satisfaction and shifting from transactional interactions to personal outcomes leading to higher retention and lower appeals.
Insights for the Healthcare Payors Sub Sector
Capitalize on the evolving landscape in the payor sector.
Our latest thinking related to Payors
No results found.
Insight
In vitro diagnostics deal making
Smaller Deals, More Partnerships, and Continued Innovation in 2022.
Insight
M&A trends in healthcare
Smart optimism, smarter diligence
Insight
Enhancing precision medicine R&D processes
How life sciences companies can navigate the R&D complexities associated with precision medicines
Insight
Local Perspectives on Rural Health: Stories from the Field Recap
In this conversation, real-world experiences and data-driven insights provide a powerful lens through which to examine the healthcare realities of rural communities, their impact on individuals, and the most effective ways to begin tackling rural health challenges.
Insight
First 100 Days: Upcoming Regulatory Signals for Healthcare/Life Sciences
Indicators of potential regulatory shifts to agency objectives and regulatory focus
Insight
Precision medicine 2.0: The multiomics era
Revolutionizing precision medicine by decoding disease mechanisms and personalizing treatments through advanced multiomics integration.
Insight
KPMG 2025 Healthcare & Life Sciences Investment Outlook
Our annual in-depth examination of the healthcare and life sciences deal market explores 2024 and the year ahead.
Insight
Inflation Reduction Act impact on biopharma portfolio strategies
An examination of potential implications for how drug manufacturers manage their portfolios in the wake of the Inflation Reduction Act
Insight
2023 KPMG Chief Risk Officer Survey: HCLS Sector Insights
Uncover the 2023 KPMG CRO Survey findings on evolving risk management strategies in the Healthcare and Life Sciences sectors.
Insight
MedTech CEOs’ pivotal role in connected health and wellness
MedTech is revolutionizing healthcare with advanced technologies like AI and robotics, enhancing provider efficiency and patient outcomes, as CEOs and strategy leaders strategically balance innovation with operational effectiveness.
Insight
Unlocking the value of Real-World Data in the era of Gen AI
How to capitalize on this dynamic opportunity for healthcare and life sciences at the intersection of RWD and GenAI.
Insight
Customer data platforms make the difference in life sciences
How data-driven strategies powered by Salesforce transform patient engagement for pharmaceutical companies
Insight
The Cost of Inaction
In this conversation, we consider the groups most at risk in a public health emergency, their needs, and the necessary structural reforms needed from government to serve all Americans.
Insight
Approaches for the evolving digital healthcare supply chain
With the pace of technological evolution, healthcare supply chains are increasingly dependent on digital solutions.
Insight
Latest Trends in M&A and Alternative Deal Structures in the Biopharma Market
Life sciences tax webcast
Insight
Key trends for PE firms in healthcare and life sciences
Competition in healthcare is intense, but PE firms can succeed if they understand the post-covid ecosystem, say KPMG’s Kristin Pothier and Glenn Mincey.
Insight
FDA's Accelerated Approval Program: Accelerated Pathway for Reform?
Reforms to FDA Accelerated Approval Program could include new confirmatory study requirements.
Insight
6 Industry use cases for intelligent forecasting
Learn about the real-world use cases of intelligent forecasting
Insight
Enabling a triple play for healthcare transformation
Healthcare organizations have long had a triple aim: cost of care, experience of care, and health outcomes
Insight
GenAI is poised to transform healthcare. Is healthcare ready?
The fast-moving tech’s revolutionary potential promises to redefine a massive industry and its slow-mover history—and the stakes have never been higher.
Insight
2024 Healthcare and Life Sciences Investment Outlook
We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.
Insight
KPMG’s Healthcare and Life Sciences Strategy practice overview
Our Strategy practice is global, delivering solutions informed by our industry depth and local market knowledge
Insight
How data and analytics are transforming healthcare
Innovations from the pandemic are now being applied to new challenges, including disparities in the delivery of health services.
Insight
How evolving market conditions are shaping healthcare and PE
KPMG hosts a Twitter Spaces conversation exploring the intersection of healthcare and private equity.
Insight
The convergence of the tech and healthcare sectors
How tech, NFTs, cyber security, and talent are impacting the healthcare industry
Insight
The future of sales for healthcare and life sciences
Emerge stronger with realigned sales models and improved performance
Insight
Blog 3: Quality Management Software in the age of the “Great Resignation”
Find out how new age digital quality management can help life sciences organizations retain talent and meet business objectives
Insight
Deglobalization: the move to a better world order
At a recent WSJ Future of Health forum, Ash Shehata, National Healthcare and Life Sciences lead spoke about Deglobalization.
Insight
Shifting from compliance to quality
Taking steps toward adopting computer software assurance (CSA) in life sciences
Insight
5 key challenges and roadblocks in biopharma commercial models
How pharmaceutical sales models impact revenue growth
Insight
Precision medicine: Data optimized. Potential realized.
Is your enterprise data optimized for precision medicine? Break down siloes to achieve breakthrough outcomes.
Insight
Podcast and Webcast
Listen to our latest podcasts and webcasts
Insight
Conferences
Learn more about our Conferences
Insight
Operations
KPMG leverages a holistic approach, helping organizations design and align operating models with business strategy.
Insight
Is deal making ready to rebound? Q2’23 M&A trends in healthcare
M&A has been flagging. But if economic headwinds ease and the valuation gap narrows, buyer interest might finally rise.
Insight
How HCLS firms can thrive during the downturn
Healthcare and life sciences leaders should be making four moves now to weather the economic downturn and set the stage for new growth
Insight
Healthcare and life sciences M&A: Poised for a rebound?
After a wild few years for HCLS, there’s reason for optimism and some new opportunities—if you know where to look.
Insight
How to make the most of a downturn: Healthcare & Life Sciences
Healthcare & life sciences firms that take strong action before a downturn—and invest during a slump—are more likely to outperform.
Insight
How to make the most of a downturn: Healthcare & Life Sciences
Healthcare & life sciences firms that take strong action before a downturn—and invest during a slump—are more likely to outperform.
Insight
Liquid Biopsy – What’s real and what’s hype?
KPMG perspective on this innovative technology
Insight
503B outsourcing facilities and pharma manufacturers
Why the growth of 503Bs may be an opportunity for traditional pharma
